Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

Drug makers trim prices for health overhaul

New York Times, June 22, 2009
The pharmaceutical industry agreed to reduce Medicare drug costs, as medical-industry groups accept cuts now in an apparent effort to stave off potentially more-burdensome givebacks under the Democrats' health-overhaul plan. Drug makers outlined a proposal to forgo $80 billion in revenue over a decade, largely by covering more of the cost of brand-name prescription drugs under Medicare. That would make up part of the $313 billion in government health-spending cuts that President Obama has proposed over a decade to help pay for the overhaul plan.